Related by context. All words. (Click for frequent words.) 73 invasive ductal carcinoma 68 histologic subtype 65 carcinoid tumor 64 ductal carcinomas 64 invasive ductal 64 nodal metastasis 64 gastric adenocarcinoma 64 thyroid carcinoma 64 pituitary adenoma 64 metastatic gastric 64 invasive carcinoma 64 histopathologic examination 64 breast carcinoma 63 Papillary 63 prostate carcinomas 63 invasive lobular 63 liver metastasis 63 Sentinel node biopsy 63 squamous cell carcinoma SCC 63 Ductal carcinoma 63 node metastases 63 MALT lymphoma 63 papillary carcinoma 63 leiomyomas 63 pathologic examination 63 situ LCIS 62 prostate carcinoma 62 nonmetastatic 62 squamous cell lung cancer 62 ductal cancer 62 basal cell carcinoma BCC 62 esophagogastric junction 62 Medullary thyroid cancer 62 mucinous 62 intraductal 62 bile duct cancers 62 urothelial carcinoma 62 spontaneous regression 62 invasive lobular carcinoma 62 papillary thyroid carcinoma 62 urothelial cancer 62 metastatic adenocarcinoma 62 recurrent ovarian 62 thyroid nodules 62 metastatic lymph nodes 62 nasopharyngeal carcinoma 62 Wilms tumors 62 malignant brain 62 fibrocystic 61 precursor lesions 61 cervical lymph node 61 surgically resected 61 LHRH receptor positive 61 hyperplastic 61 acute myeloid 61 lobular carcinoma 61 precancerous cervical 61 solar keratosis 61 neoplasias 61 nodular melanoma 61 nonmelanoma 61 hamartomas 61 nonsmall cell lung cancer 61 T1c 61 cervical carcinoma 61 Basal cell 61 recurrent metastatic 61 total thyroidectomy 61 hormone receptor negative 61 pancreatic ductal adenocarcinoma 61 percutaneous biopsy 61 peritoneal carcinomatosis 61 PCNSL 61 contralateral breast 61 malignant ovarian 61 osteoid osteoma 61 hamartoma 61 intestinal metaplasia 61 renal cell carcinomas 61 ductal adenocarcinoma 61 CIN2 + 60 thymectomy 60 pilocytic astrocytoma 60 Heavy menstrual bleeding 60 bronchogenic carcinoma 60 renal tumors 60 transabdominal 60 NMIBC 60 gastric cardia 60 Lymph node 60 Prognostic factors 60 tumor histology 60 peritoneal cancer 60 Chronic lymphocytic leukemia 60 malignant neoplasm 60 axillary dissection 60 unresectable tumors 60 papillary 60 mammographically 60 renal carcinoma 60 Hurthle cell 60 Ductal Carcinoma 60 adenomatous 60 Endometrial 60 pituitary adenomas 60 benign uterine 60 benign prostatic hyperplasia enlarged 60 colorectal gastric 60 ductal breast cancer 60 pancreatic adenocarcinoma 60 BRCA1 BRCA2 60 advanced medullary thyroid 60 leiomyosarcoma 60 epithelial ovarian 60 cutaneous melanoma 60 Squamous 60 fibroadenomas 60 oral squamous cell 60 basal cell cancers 60 anaplastic astrocytoma AA 60 fibroma 60 sarcomatoid 60 liposarcoma 60 breast carcinomas 60 endometrioid 60 metachronous 60 colorectal neoplasms 60 benign neoplasms 60 smoldering myeloma 60 paraganglioma 59 Metastatic prostate cancer 59 intraepithelial neoplasia 59 DCIS ductal carcinoma 59 pT2 59 carcinoid tumors 59 bladder ovarian 59 basal cell skin 59 operable breast cancer 59 extracapsular extension 59 melanocytic 59 Surgical resection 59 T1a 59 dysplastic lesions 59 lymphovascular invasion 59 alpha1 antitrypsin deficiency 59 alveolar soft 59 pancreatic lung 59 pulmonary metastases 59 papillary renal cell carcinoma 59 perineural invasion 59 testicular cancers 59 angiographically 59 Histopathologic examination 59 Fine needle aspiration 59 lymphomas leukemias 59 GISTs 59 benign noncancerous 59 cervix uteri 59 underwent resection 59 Waldenstrom macroglobulinemia 59 clinicopathologic 59 mesotheliomas 59 excisional biopsy 59 premalignant lesion 59 malignant lesions 59 extracapsular 59 gastric carcinoma 59 paragangliomas 59 colon rectal 59 esophageal resection 59 biliary tract cancer 59 ovarian malignancy 59 intraoperative complications 59 squamous carcinoma 59 anaplastic 59 invasive carcinomas 59 nonproliferative 59 follicular thyroid cancer 59 distinct subtypes 59 anal lesions 59 uterine cervix 59 metastatic bladder 58 immunohistochemical analysis 58 Adenomas 58 debulking surgery 58 molecular subtypes 58 histological subtype 58 atypical hyperplasia 58 endobronchial 58 prostate cancer CaP 58 situ DCIS 58 Uterine cancer 58 LVNC 58 chondrosarcoma 58 epithelial tumors 58 Estrogen receptor positive 58 lung pancreatic 58 peri implant 58 nonmelanoma skin cancers 58 transrectal ultrasound guided 58 BRCA mutation carriers 58 primary ciliary dyskinesia 58 histologic examination 58 colorectal carcinoma 58 advanced hepatocellular carcinoma 58 Endometrial cancer 58 node dissection 58 molar pregnancy 58 gynecologic malignancy 58 malignant lymphoma 58 myeloproliferative disorder 58 resection cavity 58 HER2 amplification 58 rhabdomyosarcoma rare cancer 58 axilla 58 renal biopsy 58 oligodendrogliomas 58 bladder cancers 58 benign nodules 58 thymoma 58 Basal cell carcinoma 58 polyposis 58 supratentorial 58 gadolinium enhanced 58 intracranial tumors 58 colorectal adenocarcinoma 58 lentigo maligna 58 Immunohistochemical staining 58 Histologic 58 cervical intraepithelial neoplasia 58 metastatic ovarian cancer 58 astrocytomas 58 desmoplastic 58 colorectal liver metastases 58 osteosarcomas 58 pre cancerous lesion 58 mesenteric 58 ADPKD 58 BRCA1 mutation carriers 58 aerodigestive tract 58 glioblastoma brain tumor 58 breast endometrial 58 Hepatocellular Carcinoma HCC 58 breast pancreatic 58 ultrasonographic examination 58 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 58 radiotherapy RT 58 leukemias lymphomas 58 BRAF V#E mutation 58 neuroendocrine carcinoma 58 ASCUS 58 abnormal pap smears 58 diffuse intrinsic pontine glioma 58 adenocarcinomas 58 bicuspid aortic valves 58 nodal metastases 58 neoplastic lesions 58 GIST tumors 58 extracranial 58 CP CPPS 58 sonographically 58 lung esophageal 58 lobular cancer 58 thoracic aortic aneurysm 58 Colon polyps 58 pleomorphic 58 Epithelial ovarian cancer 58 endometrial hyperplasia 57 cerebral angiography 57 GORE TAG Device 57 malignant growths 57 erythema nodosum 57 FDG PET imaging 57 Barrett mucosa 57 transitional cell carcinoma 57 oncogenic mutations 57 undergoing radical cystectomy 57 recurrent bladder 57 Benign tumors 57 colorectal adenoma 57 invasive ductal breast cancer 57 artery stenosis 57 Meningiomas 57 PNET 57 serous ovarian cancer 57 anaplastic astrocytoma 57 tumors GIST 57 FDG-PET/CT 57 metastatic lung cancer 57 normal karyotype 57 cervical prostate 57 differentiated thyroid 57 prostate adenocarcinoma 57 hydronephrosis 57 colonic polyps 57 Human papillomavirus 57 bladder tumors 57 thermogram 57 EGFR mutation positive 57 axillary lymph nodes 57 B Cell Lymphoma 57 upper gastrointestinal endoscopy 57 liver resection 57 lymphocytic leukemia 57 bladder prostate 57 preoperative chemotherapy 57 fibrocystic disease 57 intraperitoneal therapy 57 lobular carcinomas 57 precancerous condition 57 malignant fibrous histiocytoma 57 urolithiasis 57 Gorlin syndrome 57 progesterone receptor negative 57 oesophageal adenocarcinoma 57 thromboembolic disease 57 ovarian breast 57 locoregional recurrence 57 neuroendocrine cancers 57 vaginal lesions 57 esophageal gastric 57 proctitis 57 ovarian colon 57 HGPIN 57 carcinoids 57 membranous nephropathy 57 metastatic HER2 positive 57 proliferative retinopathy 57 Benign breast 57 ultrasonographic 57 urinary bladder cancer 57 uveal melanoma 57 urethral stricture 57 completely resected 57 radical prostatectomy RP 57 malignant prostate 57 Anaplastic 57 neurofibromas 57 Mohs micrographic surgery 57 Sezary syndrome 57 sarcoid 57 endometrial cancers 57 stage IIIA 57 demyelinating 57 neoadjuvant treatment 57 spinal metastases 57 osteoma 57 microsatellite instability 57 metastatic basal cell 57 HER2 amplified 57 benign polyps 57 seminal vesicle invasion 57 pathologic diagnosis 57 chondral 57 colon resection 57 cisplatin resistant 57 fibroids endometriosis 57 ovarian pancreatic 57 ductal lobular 57 fallopian tube carcinoma 57 anti angiogenic therapy 57 lymph node removal 57 cytoreduction 57 CIN3 57 diabetes mellitus DM 57 Legg Calvé Perthes disease 57 Histological 57 meningeal 57 renal cysts 57 T2 weighted MRI 57 node metastasis 57 hepatocellular carcinomas 57 Computed tomography 56 malignant ascites 56 ipsilateral breast 56 pancreatic prostate 56 carotid stenosis 56 breast uterine 56 lung nodule 56 sonographic evaluation 56 ovarian cervical 56 localized renal 56 adjuvant radiotherapy 56 advanced adenomas 56 pancreatic ovarian 56 idiopathic pulmonary arterial hypertension 56 Synovial sarcoma 56 MGUS 56 esophageal tumors 56 haematological cancers 56 serum biomarker 56 malignant pleural mesothelioma 56 serrated polyps 56 TMPRSS2 ERG fusion 56 advanced adenoma 56 acute aortic dissection 56 incidentalomas 56 parathyroid 56 seminomas 56 submucosa 56 pathologic correlation 56 Glioblastoma Multiforme 56 cystoscopic 56 TRUS biopsy 56 Squamous cell 56 Histologically 56 bacteriuria 56 glioblastoma GBM 56 sonographically guided 56 carcinoid 56 hepatic lesions 56 hyperplastic polyps 56 underwent surgical resection 56 colorectum 56 lymph node enlargement 56 mediastinal lymph nodes 56 prostate cancer PCa 56 adenomatous polyp 56 histologically proven 56 malignant nodules 56 grade squamous intraepithelial 56 heterotaxy 56 cutaneous lupus 56 ALCL 56 bone grafting procedures 56 radiographic findings 56 tumoral 56 SIADH 56 systemic amyloidosis 56 vesicoureteral reflux VUR 56 Chlamydia trachomatis infection 56 myomas 56 urodynamic 56 endometrial carcinoma 56 HNSCC 56 adenomatous polyps 56 Adenocarcinoma 56 lymph gland 56 colorectal lung 56 parotid salivary gland 56 recurrent malignant glioma 56 meningiomas 56 haematologic 56 sonographic appearance 56 mycosis fungoides 56 rhabdoid 56 histopathological examination 56 malignant pancreatic 56 endoscopic ultrasonography 56 FDG uptake 56 Polycythemia vera 56 bronchial epithelial cells 56 chronic prostatitis 56 gross hematuria 56 Radical prostatectomy 56 lymph node biopsies 56 leukemia lymphomas 56 adenomyosis 56 gastroesophageal junction 56 cytotoxic therapies 56 carotid plaques 56 lymph node metastases 56 esophagogastroduodenoscopy 56 transfusion syndrome 56 osteochondroma 56 spontaneously regress 56 gastroduodenal 56 Acute Myeloid Leukaemia AML 56 radioiodine therapy 56 choriocarcinoma 56 carcinoma HCC 56 biliary stones 56 neoadjuvant therapy 56 discoid lupus 56 BCG refractory 56 ovary uterus 56 metastatic malignant melanoma 56 bilateral orchiectomy 56 androgen ablation 56 recurrent glioblastoma 56 dysplastic 56 retroperitoneal 56 adjuvant cisplatin 56 adnexal mass 56 malignant neoplasms 56 pT3 56 BRCA deficient 56 seminoma 56 Chronic Myelogenous Leukemia CML 56 genitourinary cancers 56 appendiceal 56 angiosarcoma 56 testicular tumors 56 ANCA associated 56 medulloblastoma malignant brain tumor 56 skeletal metastases 56 premalignant lesions 56 osteochondromas 56 extracolonic findings 56 Venous thromboembolism 56 biliary obstruction 56 precancerous polyp 56 adrenalectomy 56 lumbar disk herniation 56 chromosomal mutations 56 pheochromocytomas 56 cytologic 56 underwent radical prostatectomy 56 metastatic renal 56 polypoid 56 Gastric cancer 56 precancerous tumors 56 cervical lymph nodes 56 rectal carcinoma 56 cutaneous squamous cell carcinoma 56 chlamydial infection 56 gene BRCA2 56 abnormal genital 56 fibroadenoma 56 FGFR2 gene 56 tumor nodules 56 underarm lymph nodes 56 Acute myeloid leukemia 56 alveolar rhabdomyosarcoma 56 embryonal rhabdomyosarcoma 56 paranasal sinus 56 squamous cell cancers 56 idiopathic PAH 56 hPAM4 56 cervix vagina 56 precancers 56 HER2 expression 56 axillary lymph node 56 orthotopic 55 microvessel 55 parathyroid carcinoma 55 Charcot foot 55 diagnosing coronary artery 55 laparoscopic nephrectomy 55 distal colon 55 Non Hodgkins lymphoma 55 recurrent glioblastoma multiforme 55 bony metastases 55 kidney urologic 55 degenerative lumbar 55 clinicopathological features 55 metastatic malignant 55 pilocytic astrocytomas 55 resectable 55 concurrent chemoradiation 55 hilar 55 axillary nodes 55 transurethral 55 histologically confirmed 55 neoplasm 55 esophageal squamous cell carcinoma 55 localized prostate 55 refractory gastrointestinal stromal 55 metastatic lesions 55 lymphatic tissue 55 relapsed MM 55 non resectable metastatic 55 lymph node involvement 55 HER2 positive tumors 55 aortic root replacement 55 percutaneous drainage 55 Medulloblastoma 55 precancerous cervical lesions 55 wedge resection 55 multiforme 55 Carcinoma 55 transvaginal sonography 55 bladder colon 55 computed tomographic scan 55 prostate bladder 55 malignant lesion 55 femoral neck fractures 55 ErbB2 positive 55 intestinal polyps 55 pancreatic carcinoma 55 dystrophies 55 urologic diseases 55 chronic thromboembolic pulmonary 55 ductal 55 gastrointestinal stromal tumor 55 benign breast 55 colonoscopic 55 prostate cancer metastases 55 curative resection 55 hepatorenal syndrome 55 CTEPH 55 lung resections 55 Glioblastoma Multiforme GBM 55 surgically resectable 55 neoplastic cells 55 Postoperative complications 55 Synovial Sarcoma 55 myxoid 55 preoperative staging 55 Wilm tumor 55 underwent coronary angiography 55 deCODE ProstateCancer TM 55 bone scintigraphy 55 metaplasia 55 medullary thyroid carcinoma 55 cholelithiasis 55 anterior uveitis 55 metastatic lesion 55 anal HPV 55 transurethral resection 55 aortic coarctation 55 intrahepatic 55 lymphadenopathy 55 thyroid nodule 55 bronchogenic 55 fibrous dysplasia 55 FluCAM arm 55 Metastatic breast cancer 55 micrometastases 55 advanced neoplasia 55 treat benign prostatic 55 Helicobacter pylori infection 55 metastatic colorectal 55 extramedullary 55 fallopian tube cancers 55 perianal 55 EUS FNA 55 cardiac tamponade 55 Hashimoto thyroiditis 55 nephron sparing surgery 55 Adjuvant chemotherapy 55 neurofibroma 55 orchitis 55 recurrent glioblastoma multiforme GBM 55 histological diagnosis 55 latent celiac disease 55 pelvic lymph nodes 55 metastatic neuroendocrine tumors 55 subependymal giant cell 55 ascites fluid 55 adrenal masses 55 pancreatic endocrine 55 lymphocytic 55 mutated K ras 55 thymic carcinoma 55 primitive neuroectodermal tumor 55 benign lesion 55 wound dehiscence 55 Synovial 55 pleural effusions 55 axillary node 55 Univariate analysis 55 hepatic metastases 55 pelvic lymphadenectomy 55 prophylactic cranial irradiation 55 malignant cancerous 55 prostate pancreatic 55 tumor metastases 55 lung adenocarcinomas 55 molecular abnormalities 55 clinically detectable 55 streptococcus infection 55 pulmonary metastasis 55 sentinel nodes 55 sentinel lymph node biopsy 55 painless lump 55 pleural mesothelioma 55 osteopetrosis 55 actinic keratosis AK 55 primary hyperparathyroidism 55 scintigraphic 55 abnormal pap tests 55 micrometastasis 55 LungAlert TM 55 DU# [002] 55 bilateral oophorectomy 55 axillary lymph node dissection 55 ano genital warts 55 epithelioid 55 ovarian endometrial 55 hepatocellular carcinoma liver 55 schwannomas 55 HER2 positive breast 55 colon rectum 55 enteroviral infection 55 de novo AML 55 pre cancerous growths 55 diverticular 55 polycystic kidneys 55 neoplastic 55 Acute Leukemia 55 nodular lesions 55 post thrombotic syndrome 55 p# biomarker 55 lobular breast cancer 55 SSc 54 RRM1 54 dysplastic lesions caused 54 femoral neck fracture 54 esophagus colon 54 para aortic 54 allogeneic HSCT 54 conformal radiotherapy 54 syncope fainting 54 hyperacute 54 eccrine 54 laparoscopically assisted 54 Nodules 54 tonsillar 54 transrectal ultrasonography 54 Chronic pancreatitis 54 treat brain aneurysms 54 GBMs 54 gastrointestinal stromal tumors GISTs 54 breast lesions 54 adenoma 54 situ CIS 54 SLNB 54 T2 weighted images 54 gastric cancers 54 dysplastic nevi 54 cystic lesions 54 abnormal vaginal bleeding 54 metastatic pancreatic 54 Squamous Cell 54 calculi 54 deCODE BreastCancer 54 tracer uptake 54 lichen planus 54 HIV seropositive 54 hormonally sensitive 54 recurrent NSCLC 54 Acute Myelogenous Leukemia 54 MYCN amplification 54 Renal cell carcinoma 54 intraepithelial 54 colorectal polyp 54 arthropathy 54 hyperplasia BPH 54 granulosa cell 54 Enlarged prostate 54 neoplasms 54 bowel cancers 54 malignant phenotype 54 oropharyngeal cancer 54 abnormal uterine bleeding 54 proximal colon 54 prognostic variables 54 PCa 54 resistant hormone refractory 54 melanoma lesions 54 nonischemic 54 abdominal irradiation 54 uterus fallopian tubes 54 uterine tumors 54 atypical ductal hyperplasia 54 monoclonal gammopathy 54 metastatic brain tumor 54 Ebstein anomaly 54 ureteral stones 54 uterine fibroid 54 neoadjuvant chemoradiotherapy 54 Brain metastases 54 lymph node metastasis 54 ovarian lung 54 proximal DVT 54 Monoclonal antibody 54 external genital lesions 54 Neoplasms 54 Acute Leukaemia 54 antiangiogenic therapy 54 BRCA2 mutation carriers 54 Nonalcoholic fatty liver 54 choroidal melanoma 54 epididymitis 54 HER2 overexpression 54 Lumbar spinal stenosis 54 VATS lobectomy 54 leukaemias 54 testicular germ cell 54 metastatic bone 54 malignant tissue 54 distant metastasis 54 Pericardial 54 prospective multicenter study 54 Myelodysplastic syndrome 54 indolent lymphoma 54 rebleeding 54 infantile hemangioma 54 cisplatin chemotherapy 54 myelomas 54 deep venous thromboses 54 Pelvic Inflammatory Disease 54 interstitial fibrosis 54 Uterine fibroids 54 noncancerous tumors 54 papillomas 54 mediastinal 54 distal colon cancer 54 Myelodysplastic Syndrome 54 HPV subtypes 54 pelvic ultrasound 54 hormone refractory 54 EGFR blockers 54 radical nephrectomy 54 hepatocellular cancer 54 etiologic agent 54 teratoma 54 thyroid carcinomas 54 Epstein Barr virus EBV 54 cholangiocarcinoma 54 HER2 positive cancers 54 hyperparathyroidism 54 varicoceles 54 urothelial bladder cancer 54 Neo Bladder Augment 54 GI bleeds 54 pelvic irradiation 54 giant cell arteritis 54 tonsil cancer 54 thrombo embolic 54 ER CHOP 54 carotid artery blockage 54 pancreatic resection 54 NP CRNs 54 endometrial adenocarcinoma 54 PET CT scans 54 primary peritoneal 54 polymyalgia rheumatica 54 synovial sarcoma 54 pulmonary emboli 54 bronchoalveolar 54 B7 H3 54 colorectal metastases 54 benign proliferative breast 54 deep vein thromboses 54 radioimmunotherapy RIT 54 cervical dysplasia 54 Ultrasonographic 54 gastric corpus 54 pulmonary alveolar 54 malignant polyps 54 salpingo oophorectomy 54 endometrial biopsy 54 renal transplants 54 elevated LDH 54 lung metastasis 54 Cholangiocarcinoma 54 Her2 positive 54 autonomic dysfunction 54 pericardial effusion 54 endometrial tumors 54 distant metastases 54 Glioblastomas 54 endometrial breast 54 postoperative pathology 54 submucosal 54 DCIS lesions 54 renal parenchyma 54 bladder carcinoma 54 hematopoietic cancers 54 recurrent DVT 54 cytoreductive surgery 54 leiomyoma 54 metastatic prostate 54 lymphoproliferative disorders 54 Metastases 54 chemoembolization 54 oligodendroglioma 54 Mammastatin 54 pancreatic colon 54 NOD SCID mice 54 ARVD 54 relapsing remitting MS RRMS 54 lymphoid cells 54 schwannoma 54 telangiectasia 54 gemcitabine carboplatin 54 aneurysmal bone cyst 54 myoepithelial 53 microscopic colitis 53 posttraumatic arthritis 53 histological examination 53 sentinel lymph nodes 53 cancerous nodules 53 locoregional 53 capillary endothelial cells 53 functional mitral regurgitation 53 pulmonary dysfunction 53 Immunohistochemical analysis 53 allogeneic bone marrow 53 Glioblastoma multiforme 53 postural orthostatic tachycardia 53 transarterial 53 esophageal carcinoma 53 Stage IIB 53 diagnosed prenatally 53 ABL1 53 esophagogastric 53 chronic myeloid 53 vestibular schwannomas 53 radiofrequency ablation RFA 53 refractory prostate cancer 53 NSCLC tumors 53 Vicinium TM 53 pancreatic bladder 53 MPGN 53 skin sparing mastectomy 53 ependymoma 53 arterial calcification 53 lesional 53 osteosarcoma rare 53 geographic atrophy 53 mediastinitis 53 microscopic hematuria 53 adjuvant systemic 53 cervical neoplasia 53 torn flexor muscle 53 femoral popliteal 53 rectovaginal 53 leucopenia 53 Squamous Cell Carcinoma 53 MDCT angiography 53 thrombocytosis 53 idiopathic pulmonary 53 chorioamnionitis 53 pancreatic neuroendocrine 53 lymphangioleiomyomatosis LAM 53 Vizilite 53 tumor regressions 53 genomic alterations 53 Sjögren syndrome 53 Immunohistochemical 53 multicentric 53 abdominal computed tomography 53 medically refractory 53 Multivariate analysis 53 Severe Primary IGFD 53 malignant lymphomas 53 acoustic neuromas 53 cell acute lymphoblastic 53 ureteral stents 53 chemo immunotherapy 53 labral tears 53 lymphocytosis 53 duplex ultrasonography 53 ischemic lesions 53 biopsy specimen 53 metastatic carcinoma 53 CC genotype 53 Accelerated Partial Breast Irradiation 53 mutational status 53 N. gonorrhoeae 53 RAS mutations 53 guaiac 53 abdominal ultrasound 53 axillary 53 chemoradiation therapy 53 transthoracic 53 resectable pancreatic cancer 53 supraclavicular 53 multimodality therapy 53 IV malignant melanoma 53 Malignant glioma 53 varicella infection 53 tracheobronchial 53 neurogenic bladder 53 Capsule endoscopy 53 keratoses 53 varicocele 53 incisional hernias 53 pancreatic cysts 53 Wilms tumor 53 histologic diagnosis 53 CYT# potent vascular disrupting 53 lavage fluid 53 postoperative infection 53 grade cervical intraepithelial 53 ovarian prostate 53 polycystic ovarian disease 53 axillary node dissection 53 breast cancer recurrences 53 pleurodesis 53 squamous 53 Metastatic colorectal cancer 53 renal allograft 53 cervical vaginal 53 prostate TURP 53 autologous SCT 53 CIN3 + 53 obese postmenopausal 53 treat enlarged prostate 53 parotid 53 radiochemotherapy 53 carcinomas 53 Gliomas 53 lumbar disc herniation 53 choroidal neovascularization 53 vulvar cancers